232 related articles for article (PubMed ID: 36803676)
1. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
Powell AA; Ireland G; Leeson R; Lacey A; Ford B; Poh J; Ijaz S; Shute J; Cherepanov P; Tedder R; Bottomley C; Dawe F; Mangtani P; Jones P; Nguipdop-Djomo P; Ladhani SN;
J Infect; 2023 Apr; 86(4):361-368. PubMed ID: 36803676
[TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 Antibodies Among Children in School and Day Care in Montreal, Canada.
Zinszer K; McKinnon B; Bourque N; Pierce L; Saucier A; Otis A; Cheriet I; Papenburg J; Hamelin MÈ; Charland K; Carbonneau J; Zahreddine M; Savard A; Fortin G; Apostolatos A; Haley N; Ratté N; Laurin I; Nguyen CT; Conrod P; Boivin G; De Serres G; Quach C
JAMA Netw Open; 2021 Nov; 4(11):e2135975. PubMed ID: 34812845
[TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 infection prevention and control measures in Belgian schools between December 2020 and June 2021 and their association with seroprevalence: a cross-sectional analysis of a prospective cohort study.
Callies M; Kabouche I; Desombere I; Merckx J; Roelants M; Vermeulen M; Duysburgh E
BMC Public Health; 2023 May; 23(1):898. PubMed ID: 37194008
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneous evolution of SARS-CoV-2 seroprevalence in school-age children: Results from the school-based cohort study Ciao Corona in November-December 2021 in the canton of Zurich.
Haile SR; Raineri A; Rueegg S; Radtke T; Ulyte A; Puhan MA; Kriemler S
Swiss Med Wkly; 2023 Jan; 153():40035. PubMed ID: 36787493
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 in Mozambican primary school-aged children at Maputo City and Province: a cross-sectional study from a low-income country.
Bauhofer AFL; Ussivane É; Chissaque A; Iahaia F; Pololo R; Campos F; Miranda E; António L; Maholela P; Gatambire A; Djedje M; Ráice F; Gonçalves L; de Deus N; Inlamea O
BMC Pediatr; 2024 Jul; 24(1):425. PubMed ID: 38956534
[TBL] [Abstract][Full Text] [Related]
7. Emergence of SARS-CoV-2 Alpha (B.1.1.7) variant, infection rates, antibody seroconversion and seroprevalence rates in secondary school students and staff: Active prospective surveillance, December 2020 to March 2021, England.
Ladhani SN; Ireland G; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Aiano F; Amin-Chowdhury Z; Kall M; Borrow R; Linley E; Zambon M; Poh J; Warrener L; Lackenby A; Ellis J; Amirthalingam G; Brown KE; Ramsay ME
J Infect; 2021 Nov; 83(5):573-580. PubMed ID: 34400220
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infections in children following the full re-opening of schools and the impact of national lockdown: Prospective, national observational cohort surveillance, July-December 2020, England.
Mensah AA; Sinnathamby M; Zaidi A; Coughlan L; Simmons R; Ismail SA; Ramsay ME; Saliba V; Ladhani SN
J Infect; 2021 Apr; 82(4):67-74. PubMed ID: 33639175
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 infection and transmission in educational settings: a prospective, cross-sectional analysis of infection clusters and outbreaks in England.
Ismail SA; Saliba V; Lopez Bernal J; Ramsay ME; Ladhani SN
Lancet Infect Dis; 2021 Mar; 21(3):344-353. PubMed ID: 33306981
[TBL] [Abstract][Full Text] [Related]
10. Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021.
Jones JM; Stone M; Sulaeman H; Fink RV; Dave H; Levy ME; Di Germanio C; Green V; Notari E; Saa P; Biggerstaff BJ; Strauss D; Kessler D; Vassallo R; Reik R; Rossmann S; Destree M; Nguyen KA; Sayers M; Lough C; Bougie DW; Ritter M; Latoni G; Weales B; Sime S; Gorlin J; Brown NE; Gould CV; Berney K; Benoit TJ; Miller MJ; Freeman D; Kartik D; Fry AM; Azziz-Baumgartner E; Hall AJ; MacNeil A; Gundlapalli AV; Basavaraju SV; Gerber SI; Patton ME; Custer B; Williamson P; Simmons G; Thornburg NJ; Kleinman S; Stramer SL; Opsomer J; Busch MP
JAMA; 2021 Oct; 326(14):1400-1409. PubMed ID: 34473201
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies against SARS-CoV-2 in the Norwegian population, August 2021.
Tunheim G; Rø GØI; Chopra A; Aase A; Kran AB; Vaage JT; Lund-Johansen F; Hungnes O
Influenza Other Respir Viruses; 2022 Nov; 16(6):1004-1013. PubMed ID: 35770841
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of antibodies against SARS-CoV-2 in the school community in Campo Grande, state of Mato Grosso do Sul, Brazil, October 2021-November 2022.
Stutz C; Alcantara DMC; Dos Santos CM; Torres JM; Rodrigues R; Marcon GEB; Ferreira EC; Sarti ECFB; de Oliveira TF; Mendes FML; Lemos EF; Demarchi LHF; Lichs GGC; Zardin MCSU; Gonçalves CCM; Guilhermino JF; Perdomo RT; Fernandez ZDC
Front Immunol; 2024; 15():1354786. PubMed ID: 38596680
[TBL] [Abstract][Full Text] [Related]
13. Secondary attack rates in primary and secondary school bubbles following a confirmed case: Active, prospective national surveillance, November to December 2020, England.
Powell AA; Ireland G; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Aiano F; Hargreaves J; Langan SM; Mangtani P; Nguipdop-Djomo P; Sturgess J; Oswald W; Halliday K; Rourke E; Dawe F; Amin-Chowdhury Z; Kall M; Zambon M; Poh J; Ijaz S; Lackenby A; Elli J; Brown KE; Diamond SI; Ramsay ME; Ladhani SN
PLoS One; 2022; 17(2):e0262515. PubMed ID: 35171942
[TBL] [Abstract][Full Text] [Related]
14. Feasibility and acceptability of SARS-CoV-2 testing and surveillance in primary school children in England: Prospective, cross-sectional study.
Aiano F; Jones SEI; Amin-Chowdhury Z; Flood J; Okike I; Brent A; Brent B; Beckmann J; Garstang J; Ahmad S; Baawuah F; Ramsay ME; Ladhani SN
PLoS One; 2021; 16(8):e0255517. PubMed ID: 34449784
[TBL] [Abstract][Full Text] [Related]
15. Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools.
Ulyte A; Radtke T; Abela IA; Haile SR; Berger C; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ; 2021 Mar; 372():n616. PubMed ID: 33731327
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
17. Variation in SARS-CoV-2 seroprevalence across districts, schools and classes: baseline measurements from a cohort of primary and secondary school children in Switzerland.
Ulyte A; Radtke T; Abela IA; Haile SR; Blankenberger J; Jung R; Capelli C; Berger C; Frei A; Huber M; Schanz M; Schwarzmueller M; Trkola A; Fehr J; Puhan MA; Kriemler S
BMJ Open; 2021 Jul; 11(7):e047483. PubMed ID: 34312201
[TBL] [Abstract][Full Text] [Related]
18. The COVID-19 Schools Infection Survey in England: Protocol and Participation Profile for a Prospective Observational Cohort Study.
Halliday KE; Nguipdop-Djomo P; Oswald WE; Sturgess J; Allen E; Sundaram N; Ireland G; Poh J; Ijaz S; Shute J; Diamond I; Rourke E; Dawe F; Judd A; Clark T; Edmunds WJ; Bonell C; Mangtani P; Ladhani SN; Langan SM; Hargreaves J;
JMIR Res Protoc; 2022 Nov; 11(11):e34075. PubMed ID: 35635843
[TBL] [Abstract][Full Text] [Related]
19. Utility of Newborn Dried Blood Spots to Ascertain Seroprevalence of SARS-CoV-2 Antibodies Among Individuals Giving Birth in New York State, November 2019 to November 2021.
Damjanovic A; Styer LM; Nemeth K; Yauney E; Rock JM; Bievenue R; Hoen R; Ehrbar D; Kay DM; Caggana M; Parker MM
JAMA Netw Open; 2022 Aug; 5(8):e2227995. PubMed ID: 35994287
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology of SARS-CoV-2 infection among staff and students in a cohort of English primary and secondary schools during 2020-2021.
Hargreaves JR; Langan SM; Oswald WE; Halliday KE; Sturgess J; Phelan J; Nguipdop-Djomo P; Ford B; Allen E; Sundaram N; Ireland G; Poh J; Ijaz S; Diamond I; Rourke E; Dawe F; Judd A; Warren-Gash C; Clark TG; Glynn JR; Edmunds WJ; Bonell C; Mangtani P; Ladhani SN;
Lancet Reg Health Eur; 2022 Oct; 21():100471. PubMed ID: 36035630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
